Loading video...

Video Failed to Load

Go Home

🚨 Why did Rep. Scott Hilton (R–Peachtree Corners) side with Democrats by voting against medical freedom for Georgians? In the 3/19/26 Public & Community Health Committee: ⏱️ Hilton arrived 22 mins into a 30-min hearing ⏱️ 26:23 – Dem motion to REMOVE OTC ivermectin ⏱️ 28:11 – Hilton =...

WhatmattersinG's profile picture

WhatmattersinGeorgia

3,609 subscribers

38,327 views • 5 months ago •via X (Twitter)

News & Politics
LIVE

Anya Rossi• Live Now

Private livecam show

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

1/ Dr. Michelle Au (Georga House Rep- District 50- Johns Creek) delivered the House Minority Report opposing SB 440—arguing ivermectin should not even be part of the discussion, citing lack of evidence and potential toxicity. But if “science” is the standard in Georgia lawmaking, it must be applied consistently: Why is uncertainty tolerated for novel products authorized under emergency conditions—while discussion of low-cost, repurposed generics is shut down outright? That’s not a scientific standard. That’s a policy choice. #GAPol JonBurnsGA GA House Republicans Georgia House of Representatives Chuck Efstration Soo Hong Representative James Burchett Ginny Ehrhart Emory Dunahoo Jr. Rep. Karen Mathiak Rep. Lee Hawkins Sharon Cooper Todd Jones Trey Kelley Tyler Paul Smith David Clark Lt. Governor Burt Jones GA Senate Republicans Georgia State Senate Jason R. Anavitarte Randy Robertson John Albers Kay kirkpatrick Senator Clint Dixon Rick Williams Bo Hatchett Steven McNeel Brian Strickland For Georgia Bill Cowsert Blake Tillery GoochForGeorgia Senator Greg Dolezal Matt Brass
10:17

1/ Dr. Michelle Au (Georga House Rep- District 50- Johns Creek) delivered the House Minority Report opposing SB 440—arguing ivermectin should not even be part of the discussion, citing lack of evidence and potential toxicity. But if “science” is the standard in Georgia lawmaking, it must be applied consistently: Why is uncertainty tolerated for novel products authorized under emergency conditions—while discussion of low-cost, repurposed generics is shut down outright? That’s not a scientific standard. That’s a policy choice. #GAPol JonBurnsGA GA House Republicans Georgia House of Representatives Chuck Efstration Soo Hong Representative James Burchett Ginny Ehrhart Emory Dunahoo Jr. Rep. Karen Mathiak Rep. Lee Hawkins Sharon Cooper Todd Jones Trey Kelley Tyler Paul Smith David Clark Lt. Governor Burt Jones GA Senate Republicans Georgia State Senate Jason R. Anavitarte Randy Robertson John Albers Kay kirkpatrick Senator Clint Dixon Rick Williams Bo Hatchett Steven McNeel Brian Strickland For Georgia Bill Cowsert Blake Tillery GoochForGeorgia Senator Greg Dolezal Matt Brass

WhatmattersinGeorgia

33,935 views • 4 months ago

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.
9:41

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.

Bobby

160,046 views • 1 year ago

The LARGEST systematic review study ever conducted on ivermectin use in cancer patients identified 14 distinct anticancer mechanisms across 12 cancer types and found no safety concerns. Meanwhile, a recent study reported COMPLETE REMISSION of Stage IV cancers with fenbendazole.
1:15

The LARGEST systematic review study ever conducted on ivermectin use in cancer patients identified 14 distinct anticancer mechanisms across 12 cancer types and found no safety concerns. Meanwhile, a recent study reported COMPLETE REMISSION of Stage IV cancers with fenbendazole.

Nicolas Hulscher, MPH

90,276 views • 6 months ago

🚨 WHY ARE THERE OVER 400 PUBLISHED PAPERS ON IVERMECTIN AND CANCER? Because researchers discovered something unexpected. Ivermectin doesn't just target parasites. According to preclinical research, it appears to interact with cancer cells through multiple biological pathways. One of the most discussed? 📌 Cancer Stem Cells These are the cells believed to survive treatment, remain dormant for years, and potentially contribute to recurrence and spread. According to Dr. William Makis: 💊 Chemotherapy primarily targets rapidly dividing cancer cells. 💊 Ivermectin has been studied for its potential effects on cancer stem cells. That's why some researchers believe the combination deserves attention. But that's only part of the story. Researchers have also investigated ivermectin's potential ability to: ✅ Target cancer stem cells ✅ Influence tumor signaling pathways ✅ Alter cancer cell behavior ✅ Reverse chemotherapy resistance One of the most fascinating findings involves chemotherapy resistance. Over time, some cancer cells develop the ability to push chemotherapy drugs back out of the cell. Researchers have reported that ivermectin may interfere with these resistance mechanisms, potentially making cancer cells susceptible again. And then there's Fenbendazole and Mebendazole. While Ivermectin is being studied for one set of mechanisms, Fenbendazole and Mebendazole appear to work differently. Researchers have investigated their potential ability to: 📌 Block glucose transporters on cancer cells 📌 Reduce the cell's ability to use glucose as fuel 📌 Interfere with pathways associated with tumor growth Think about that. Different compounds. Different mechanisms. The same goal. That's why scientists continue publishing study after study. Not because these compounds are a fad. Because researchers keep uncovering new biological pathways worth investigating. And that's why the conversation around Ivermectin, Fenbendazole, and Mebendazole continues to grow. 💊 If you’re looking into these drugs, check out Ivermectin, Fenbendazole, and Mebendazole from RXMEDS.STORE. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #CancerStemCells #RepurposedDrugs #CancerBiology #RxMeds
3:32

🚨 WHY ARE THERE OVER 400 PUBLISHED PAPERS ON IVERMECTIN AND CANCER? Because researchers discovered something unexpected. Ivermectin doesn't just target parasites. According to preclinical research, it appears to interact with cancer cells through multiple biological pathways. One of the most discussed? 📌 Cancer Stem Cells These are the cells believed to survive treatment, remain dormant for years, and potentially contribute to recurrence and spread. According to Dr. William Makis: 💊 Chemotherapy primarily targets rapidly dividing cancer cells. 💊 Ivermectin has been studied for its potential effects on cancer stem cells. That's why some researchers believe the combination deserves attention. But that's only part of the story. Researchers have also investigated ivermectin's potential ability to: ✅ Target cancer stem cells ✅ Influence tumor signaling pathways ✅ Alter cancer cell behavior ✅ Reverse chemotherapy resistance One of the most fascinating findings involves chemotherapy resistance. Over time, some cancer cells develop the ability to push chemotherapy drugs back out of the cell. Researchers have reported that ivermectin may interfere with these resistance mechanisms, potentially making cancer cells susceptible again. And then there's Fenbendazole and Mebendazole. While Ivermectin is being studied for one set of mechanisms, Fenbendazole and Mebendazole appear to work differently. Researchers have investigated their potential ability to: 📌 Block glucose transporters on cancer cells 📌 Reduce the cell's ability to use glucose as fuel 📌 Interfere with pathways associated with tumor growth Think about that. Different compounds. Different mechanisms. The same goal. That's why scientists continue publishing study after study. Not because these compounds are a fad. Because researchers keep uncovering new biological pathways worth investigating. And that's why the conversation around Ivermectin, Fenbendazole, and Mebendazole continues to grow. 💊 If you’re looking into these drugs, check out Ivermectin, Fenbendazole, and Mebendazole from RXMEDS.STORE. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #CancerStemCells #RepurposedDrugs #CancerBiology #RxMeds

RXMEDS.STORE

16,612 views • 2 months ago

🚨 "Researchers Have Identified Around a Dozen Anti Cancer Mechanisms for Ivermectin." Dr. Makis Explains Why It Keeps Getting Studied. Most people know Ivermectin as an antiparasitic medicine. According to Dr. William Makis, researchers have now identified around a dozen different mechanisms through which Ivermectin has shown anticancer activity in laboratory and preclinical studies. That's why scientists continue investigating it decades after its introduction. One story Dr. Makis shared especially stood out. A woman being treated for breast cancer contacted him because her tumor was shrinking. But that wasn't what excited her the most. According to Dr. Makis, she told him that uterine fibroids she'd lived with for nearly 20 years had disappeared during the same period. He says researchers have investigated some of the same cellular pathways involved in the growth of certain benign tumors, including fibroids. So what exactly are researchers studying? 📌 Cancer Stem Cells Dr. Makis says laboratory research suggests Ivermectin may interfere with cancer stem cells, which are believed to play an important role in tumor growth, spread, and recurrence. 📌 Chemotherapy Resistance He also says researchers have investigated whether Ivermectin may help reverse molecular mechanisms associated with chemotherapy resistance in cancer cells. 📌 Tumor Growth Pathways According to Dr. Makis, studies suggest Ivermectin may influence signaling pathways involved in tumor proliferation, making it an ongoing area of scientific investigation. He also discussed laboratory research in mice showing that Ivermectin affected rapidly proliferating lymphoma cells while leaving normal spleen cells largely unaffected. According to Dr. Makis, researchers still don't fully understand how this selectivity occurs at the molecular level. One molecule. Around a dozen proposed anticancer mechanisms. That's one reason Ivermectin continues to attract scientific attention. Another fact many people overlook... 🏆 Ivermectin was awarded the 2015 Nobel Prize in Physiology or Medicine for its impact on treating parasitic diseases. Since then, researchers around the world have continued exploring whether the same molecule may have applications beyond parasitic infections. Whether future clinical trials ultimately confirm, refine, or challenge today's findings remains to be seen. But the scientific interest hasn't disappeared. In many ways, it's still growing. One medicine. Around a dozen proposed anticancer mechanisms. Decades of research. And scientists are still asking new questions. 🔁 Share this so others can learn why Ivermectin continues to be one of the most discussed repurposed medicines in cancer research. 💊 Whether you're researching Ivermectin, Fenbendazole, or Mebendazole, find pharmaceutical-grade options you can trust at RXMEDS.STORE. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #MedicalResearch #Cancer #NobelPrize #MakisMD
4:38

🚨 "Researchers Have Identified Around a Dozen Anti Cancer Mechanisms for Ivermectin." Dr. Makis Explains Why It Keeps Getting Studied. Most people know Ivermectin as an antiparasitic medicine. According to Dr. William Makis, researchers have now identified around a dozen different mechanisms through which Ivermectin has shown anticancer activity in laboratory and preclinical studies. That's why scientists continue investigating it decades after its introduction. One story Dr. Makis shared especially stood out. A woman being treated for breast cancer contacted him because her tumor was shrinking. But that wasn't what excited her the most. According to Dr. Makis, she told him that uterine fibroids she'd lived with for nearly 20 years had disappeared during the same period. He says researchers have investigated some of the same cellular pathways involved in the growth of certain benign tumors, including fibroids. So what exactly are researchers studying? 📌 Cancer Stem Cells Dr. Makis says laboratory research suggests Ivermectin may interfere with cancer stem cells, which are believed to play an important role in tumor growth, spread, and recurrence. 📌 Chemotherapy Resistance He also says researchers have investigated whether Ivermectin may help reverse molecular mechanisms associated with chemotherapy resistance in cancer cells. 📌 Tumor Growth Pathways According to Dr. Makis, studies suggest Ivermectin may influence signaling pathways involved in tumor proliferation, making it an ongoing area of scientific investigation. He also discussed laboratory research in mice showing that Ivermectin affected rapidly proliferating lymphoma cells while leaving normal spleen cells largely unaffected. According to Dr. Makis, researchers still don't fully understand how this selectivity occurs at the molecular level. One molecule. Around a dozen proposed anticancer mechanisms. That's one reason Ivermectin continues to attract scientific attention. Another fact many people overlook... 🏆 Ivermectin was awarded the 2015 Nobel Prize in Physiology or Medicine for its impact on treating parasitic diseases. Since then, researchers around the world have continued exploring whether the same molecule may have applications beyond parasitic infections. Whether future clinical trials ultimately confirm, refine, or challenge today's findings remains to be seen. But the scientific interest hasn't disappeared. In many ways, it's still growing. One medicine. Around a dozen proposed anticancer mechanisms. Decades of research. And scientists are still asking new questions. 🔁 Share this so others can learn why Ivermectin continues to be one of the most discussed repurposed medicines in cancer research. 💊 Whether you're researching Ivermectin, Fenbendazole, or Mebendazole, find pharmaceutical-grade options you can trust at RXMEDS.STORE. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #MedicalResearch #Cancer #NobelPrize #MakisMD

RXMEDS.STORE

18,067 views • 26 days ago

🚨 76-YEAR-OLD WITH GLEASON 7 PROSTATE CANCER TAKES IVERMECTIN. 12 WEEKS LATER, PET SCAN SHOWS NOTHING. A doctor shared the story of a 76-year-old veteran who had been diagnosed with Gleason 7 prostate cancer. According to the doctor, the patient began taking 12 mg of Ivermectin daily. After eight weeks, he continued with follow-up testing. At around 12 weeks, he underwent a specialized PET scan looking for abnormalities associated with the prostate. The doctor says the scan could no longer find the cancerous abnormalities. There was another change too. His PSA, which had been 12.6 when the cancer was initially diagnosed, had dropped to 5.3. That is a significant change in the numbers the doctor shared. The story raises an obvious question about the potential role of Ivermectin in prostate cancer, particularly given the growing interest in repurposing older medicines for oncology. Ivermectin is already well established as an antiparasitic medicine, while research into its potential anticancer effects continues to explore mechanisms involving cancer cell growth, survival and signaling. Could Ivermectin deserve a closer look in prostate cancer research?
0:48

🚨 76-YEAR-OLD WITH GLEASON 7 PROSTATE CANCER TAKES IVERMECTIN. 12 WEEKS LATER, PET SCAN SHOWS NOTHING. A doctor shared the story of a 76-year-old veteran who had been diagnosed with Gleason 7 prostate cancer. According to the doctor, the patient began taking 12 mg of Ivermectin daily. After eight weeks, he continued with follow-up testing. At around 12 weeks, he underwent a specialized PET scan looking for abnormalities associated with the prostate. The doctor says the scan could no longer find the cancerous abnormalities. There was another change too. His PSA, which had been 12.6 when the cancer was initially diagnosed, had dropped to 5.3. That is a significant change in the numbers the doctor shared. The story raises an obvious question about the potential role of Ivermectin in prostate cancer, particularly given the growing interest in repurposing older medicines for oncology. Ivermectin is already well established as an antiparasitic medicine, while research into its potential anticancer effects continues to explore mechanisms involving cancer cell growth, survival and signaling. Could Ivermectin deserve a closer look in prostate cancer research?

Joe Tippens

38,802 views • 13 days ago

Ivermectin exerts more than 12 distinct anticancer mechanisms on more than 12 types of cancer, according to hundreds of studies. The NIH has officially recognized it and has launched studies on ivermectin's ability to eliminate cancer cells.
1:01

Ivermectin exerts more than 12 distinct anticancer mechanisms on more than 12 types of cancer, according to hundreds of studies. The NIH has officially recognized it and has launched studies on ivermectin's ability to eliminate cancer cells.

Whiplash347

26,054 views • 5 months ago

German oncologists have revealed that parasites may play a key role in the development of cancer and now research is showing that Ivermectin, a trusted anti-parasitic with decades of safe use, could also have powerful anticancer effects. This Drug could change cancer treatment.
2:20

German oncologists have revealed that parasites may play a key role in the development of cancer and now research is showing that Ivermectin, a trusted anti-parasitic with decades of safe use, could also have powerful anticancer effects. This Drug could change cancer treatment.

Amelia Brown

2,636,406 views • 1 year ago

🚨Multiple Studies Confirm Ivermectin, Fenbendazole, & Mushrooms Exhibit Potent Anti-Cancer Activity via 20+ Mechanisms 💠Ivermectin: ✅ Proven safe—even with chemo ✅ Widespread anecdotal reports of remission ✅ 14 distinct anticancer mechanisms (systematic review) ✅ Targets glioblastoma, leukemia, ovarian, cervical cancers & more 💠Fenbendazole: ✅ Linked to remission of Stage IV cancers (Makis et al) ✅ Strong safety profile in humans ✅ Disrupts tumor metabolism & growth pathways 💠Medicinal Mushrooms (Cordyceps, Turkey Tail, Reishi): ✅ Boost NK & T cells ✅ Block angiogenesis ✅ Trigger apoptosis ✅ ↓ cancer risk by 34% (meta-analysis) ✅ ↑ survival & QoL (39 clinical trials) It’s time for cancer therapies that HEAL the body—not destroy it.
1:21

🚨Multiple Studies Confirm Ivermectin, Fenbendazole, & Mushrooms Exhibit Potent Anti-Cancer Activity via 20+ Mechanisms 💠Ivermectin: ✅ Proven safe—even with chemo ✅ Widespread anecdotal reports of remission ✅ 14 distinct anticancer mechanisms (systematic review) ✅ Targets glioblastoma, leukemia, ovarian, cervical cancers & more 💠Fenbendazole: ✅ Linked to remission of Stage IV cancers (Makis et al) ✅ Strong safety profile in humans ✅ Disrupts tumor metabolism & growth pathways 💠Medicinal Mushrooms (Cordyceps, Turkey Tail, Reishi): ✅ Boost NK & T cells ✅ Block angiogenesis ✅ Trigger apoptosis ✅ ↓ cancer risk by 34% (meta-analysis) ✅ ↑ survival & QoL (39 clinical trials) It’s time for cancer therapies that HEAL the body—not destroy it.

Nicolas Hulscher, MPH

199,492 views • 11 months ago

Legalize OTC Ivermectin! HB3175 is filed and waiting for a committee hearing. Contact your Texas State Rep and Senator and ask them to support HB3175.
1:48

Legalize OTC Ivermectin! HB3175 is filed and waiting for a committee hearing. Contact your Texas State Rep and Senator and ask them to support HB3175.

Wes Virdell, TX State Rep

99,859 views • 1 year ago

🚨 IVERMECTIN AND CANCER: WHAT THE RESEARCH ACTUALLY SHOWS A researcher recently shared what they found after looking into Ivermectin and cancer. They discovered over 300 peer-reviewed papers on PubMed examining Ivermectin in cancer. While most of this research is preclinical (cell lines, mice, and rats), the body of work is extensive and covers many different mechanisms. Key points from the research include: ✅ Ivermectin appears to target cancer stem cells, which standard chemotherapy often does not effectively kill. ✅ It can help reverse multi-drug resistance in cancer cells and may sensitise them to chemotherapy. ✅ It acts as a radio sensitizer, potentially making cancer cells more responsive to radiation. ✅ It can inhibit angiogenesis, limiting the tumor’s ability to form new blood vessels. ✅ It may inhibit enzymes involved in cancer cell detachment and spread, reducing the potential for metastasis. The researcher noted that Ivermectin is an off-patent, low-cost drug. Because of this, there has been little financial incentive to fund large-scale human trials in oncology, which is why most of the data remains preclinical.
5:23

🚨 IVERMECTIN AND CANCER: WHAT THE RESEARCH ACTUALLY SHOWS A researcher recently shared what they found after looking into Ivermectin and cancer. They discovered over 300 peer-reviewed papers on PubMed examining Ivermectin in cancer. While most of this research is preclinical (cell lines, mice, and rats), the body of work is extensive and covers many different mechanisms. Key points from the research include: ✅ Ivermectin appears to target cancer stem cells, which standard chemotherapy often does not effectively kill. ✅ It can help reverse multi-drug resistance in cancer cells and may sensitise them to chemotherapy. ✅ It acts as a radio sensitizer, potentially making cancer cells more responsive to radiation. ✅ It can inhibit angiogenesis, limiting the tumor’s ability to form new blood vessels. ✅ It may inhibit enzymes involved in cancer cell detachment and spread, reducing the potential for metastasis. The researcher noted that Ivermectin is an off-patent, low-cost drug. Because of this, there has been little financial incentive to fund large-scale human trials in oncology, which is why most of the data remains preclinical.

Joe Tippens

20,411 views • 1 month ago

84.4% of cancer patients taking ivermectin + mebendazole declared NO EVIDENCE OF DISEASE, TUMOR SHRINKAGE, or CANCER STABILIZATION after 6 months. HUNDREDS of preclinical studies explain why: anti-parasitics exert over 12 anti-cancer mechanisms across more than 12 cancer types.
1:44

84.4% of cancer patients taking ivermectin + mebendazole declared NO EVIDENCE OF DISEASE, TUMOR SHRINKAGE, or CANCER STABILIZATION after 6 months. HUNDREDS of preclinical studies explain why: anti-parasitics exert over 12 anti-cancer mechanisms across more than 12 cancer types.

Nicolas Hulscher, MPH

1,052,511 views • 4 months ago

“There’s literally over 100 studies showing IVERMECTIN has over 12 distinct anti-cancer mechanisms across 12 cancer types. Glioblastoma brain tumors — one of the most lethal cancers in existence — Ivermectin shrunk the glioblastomas 70% in 10 days.” ~Nicolas Hulscher, MPH
0:37

“There’s literally over 100 studies showing IVERMECTIN has over 12 distinct anti-cancer mechanisms across 12 cancer types. Glioblastoma brain tumors — one of the most lethal cancers in existence — Ivermectin shrunk the glioblastomas 70% in 10 days.” ~Nicolas Hulscher, MPH

Valerie Anne Smith

30,754 views • 4 months ago

7 Compelling Reasons Why Ivermectin Is a ‘Powerful Drug’ for Fighting Cancer Ivermectin is often recognized–2nd to penicillin–for having the greatest impact on human health. Its discovery even won the Nobel Prize. It is safer than Tylenol and brought river blindness to the brink of extinction, but the propagandists told you it was a “dangerous horse dewormer.” Well, it now turns out that ivermectin is not only an effective treatment for COVID-19, but it could also be a “powerful drug” for fighting cancer. Here are 7 reasons why. 1. Multiple Anti-Cancer Effects: Ivermectin impacts at least nine well-defined cancer targets, according to Dr. Alfonso Dueñas-González, an oncologist and senior researcher. He states, "There are at least nine perfectly defined cancer targets affected by ivermectin." 2. Enhances Effects of Chemotherapy and Radiation: Ivermectin not only targets tumor stem cells and promotes cancer cell death but also "enhances the effects of chemo and radiation therapy." This broad impact on the immune system increases the offense against cancers, making it a versatile adjunct to conventional treatments. 3. Inhibits Cancer Cell Cycles: The drug prevents the formation of new cancer cells by inhibiting cancer cell cycles and inducing mitochondrial stress, which leads to the killing of cancer cells. This mechanism is crucial for stopping the proliferation of cancerous cells. 4. Prevents Formation of New Blood Vessels Near Cancer Cells: Ivermectin prevents cancer survival by inhibiting the formation of new blood vessels that transport energy and fuel to cancers. This action starves the cancer cells, hindering their growth and spread. 5. Synergizes with Immunotherapy: Dr. Peter P. Lee, chair of immuno-oncology at the City of Hope, found that ivermectin could synergize with immune checkpoint inhibitor anti-PD1, enhancing the body's immune response to fight cancer. "What we’re learning is that ivermectin is going to be a very powerful drug in the context of really carefully developed immunotherapy combinations," he said. 6. Targets Cancer Stem Cells: Ivermectin preferentially targets cancer stem cells, which are a driver of cancer tumors and relapses. By focusing on these cells, ivermectin attacks the root of cancer's resilience and ability to recur. 7. The Curious Case of Rick Alderson: Mr. Alderson, a retired sawmill worker, “was a dead man walking” and given 6 months to live after his terminal colon cancer had metastasized and spread to his liver, where it had formed 25 distinct tumors. After starting ivermectin, Rick Alderson's carcinoembryonic antigen (CEA) levels, which are markers for tumor activity, dropped significantly from 1,498 ng/mL to 13.9 ng/mL in a matter of months. Of the 25 tumors in Mr. Alderson's liver, only three remained after his treatment with ivermectin and chemotherapy, indicating a substantial reduction in tumor burden. Mr. Alderson lived for two more years beyond his initial six-month prognosis, which his wife attributes to the use of ivermectin alongside chemotherapy.
3:43

7 Compelling Reasons Why Ivermectin Is a ‘Powerful Drug’ for Fighting Cancer Ivermectin is often recognized–2nd to penicillin–for having the greatest impact on human health. Its discovery even won the Nobel Prize. It is safer than Tylenol and brought river blindness to the brink of extinction, but the propagandists told you it was a “dangerous horse dewormer.” Well, it now turns out that ivermectin is not only an effective treatment for COVID-19, but it could also be a “powerful drug” for fighting cancer. Here are 7 reasons why. 1. Multiple Anti-Cancer Effects: Ivermectin impacts at least nine well-defined cancer targets, according to Dr. Alfonso Dueñas-González, an oncologist and senior researcher. He states, "There are at least nine perfectly defined cancer targets affected by ivermectin." 2. Enhances Effects of Chemotherapy and Radiation: Ivermectin not only targets tumor stem cells and promotes cancer cell death but also "enhances the effects of chemo and radiation therapy." This broad impact on the immune system increases the offense against cancers, making it a versatile adjunct to conventional treatments. 3. Inhibits Cancer Cell Cycles: The drug prevents the formation of new cancer cells by inhibiting cancer cell cycles and inducing mitochondrial stress, which leads to the killing of cancer cells. This mechanism is crucial for stopping the proliferation of cancerous cells. 4. Prevents Formation of New Blood Vessels Near Cancer Cells: Ivermectin prevents cancer survival by inhibiting the formation of new blood vessels that transport energy and fuel to cancers. This action starves the cancer cells, hindering their growth and spread. 5. Synergizes with Immunotherapy: Dr. Peter P. Lee, chair of immuno-oncology at the City of Hope, found that ivermectin could synergize with immune checkpoint inhibitor anti-PD1, enhancing the body's immune response to fight cancer. "What we’re learning is that ivermectin is going to be a very powerful drug in the context of really carefully developed immunotherapy combinations," he said. 6. Targets Cancer Stem Cells: Ivermectin preferentially targets cancer stem cells, which are a driver of cancer tumors and relapses. By focusing on these cells, ivermectin attacks the root of cancer's resilience and ability to recur. 7. The Curious Case of Rick Alderson: Mr. Alderson, a retired sawmill worker, “was a dead man walking” and given 6 months to live after his terminal colon cancer had metastasized and spread to his liver, where it had formed 25 distinct tumors. After starting ivermectin, Rick Alderson's carcinoembryonic antigen (CEA) levels, which are markers for tumor activity, dropped significantly from 1,498 ng/mL to 13.9 ng/mL in a matter of months. Of the 25 tumors in Mr. Alderson's liver, only three remained after his treatment with ivermectin and chemotherapy, indicating a substantial reduction in tumor burden. Mr. Alderson lived for two more years beyond his initial six-month prognosis, which his wife attributes to the use of ivermectin alongside chemotherapy.

The Vigilant Fox 🦊

532,851 views • 2 years ago

Ivermectin— 7 Anti-Cancer Mechanisms of Action
1:23

Ivermectin— 7 Anti-Cancer Mechanisms of Action

Diana ❤️🇺🇸🙏🐸

333,269 views • 1 year ago

84.4% of cancer patients taking ivermectin declared COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED TUMOR GROWTH The LARGEST human ivermectin cancer study EVER conducted is now PEER-REVIEWED and PUBLISHED by the International Institute of Anticancer Research. We are WINNING.
0:58

84.4% of cancer patients taking ivermectin declared COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED TUMOR GROWTH The LARGEST human ivermectin cancer study EVER conducted is now PEER-REVIEWED and PUBLISHED by the International Institute of Anticancer Research. We are WINNING.

Nicolas Hulscher, MPH

185,107 views • 2 months ago

🚨 A HARVARD TRAINED MD JUST EXPLAINED WHY IVERMECTIN IS BEING STUDIED IN CANCER RESEARCH AGAIN And the internet is paying VERY close attention. Dr. Shintani says researchers have explored how Ivermectin may interact with cancer cells in laboratory and preclinical studies involving: • Breast cancer • Prostate cancer • Colon cancer • Lung cancer • Leukemia • Liver cancer • Stomach cancer Why scientists are interested: ✅ Studies suggest Ivermectin may trigger apoptosis, also known as programmed cancer cell death ✅ Researchers are investigating how it may affect tumor growth pathways and cancer stem-like cells ✅ Some preclinical studies are exploring Ivermectin alongside chemotherapy in laboratory models And THAT is why repurposed medicine conversations have exploded across podcasts, TikTok, X, and cancer forums worldwide. Not because the science is settled. Because people are shocked that a low-cost anti-parasitic drug is even being discussed in cancer research at all. But whether critics like it or not… The public conversation around repurposed drugs is getting impossible to ignore.
0:59

🚨 A HARVARD TRAINED MD JUST EXPLAINED WHY IVERMECTIN IS BEING STUDIED IN CANCER RESEARCH AGAIN And the internet is paying VERY close attention. Dr. Shintani says researchers have explored how Ivermectin may interact with cancer cells in laboratory and preclinical studies involving: • Breast cancer • Prostate cancer • Colon cancer • Lung cancer • Leukemia • Liver cancer • Stomach cancer Why scientists are interested: ✅ Studies suggest Ivermectin may trigger apoptosis, also known as programmed cancer cell death ✅ Researchers are investigating how it may affect tumor growth pathways and cancer stem-like cells ✅ Some preclinical studies are exploring Ivermectin alongside chemotherapy in laboratory models And THAT is why repurposed medicine conversations have exploded across podcasts, TikTok, X, and cancer forums worldwide. Not because the science is settled. Because people are shocked that a low-cost anti-parasitic drug is even being discussed in cancer research at all. But whether critics like it or not… The public conversation around repurposed drugs is getting impossible to ignore.

Joe Tippens

10,621 views • 3 months ago

Nearly HALF of cancer patients declared COMPLETE REMISSION or TUMOR SHRINKAGE in the largest human ivermectin cancer study ever conducted. Our study is now PEER-REVIEWED and PUBLISHED by the International Institute of Anticancer Research.
1:15

Nearly HALF of cancer patients declared COMPLETE REMISSION or TUMOR SHRINKAGE in the largest human ivermectin cancer study ever conducted. Our study is now PEER-REVIEWED and PUBLISHED by the International Institute of Anticancer Research.

Nicolas Hulscher, MPH

53,220 views • 2 months ago